Elvira Sanz is a Doctor in Pharmacy by the Complutense University of Madrid, with Extraordinary Prize of End of Career and graduated with an International MBA by the Business School ESDEN, first in her class. She has undertaken postgraduate courses in prestigious universities and international business schools, such as the Harvard Business School and Wharton University.
She has extensive experience in the pharmaceutical industry which she has accumulated over 25 years, starting as Research Scientist and occupying positions of growing responsibility across different business areas for MSD, Roche and Cyanamid.
In 1994, she joined Wyeth Farma as Director of Registrations and New Products. She was appointed in 1996 as Marketing Director and subsequently, in 1998, Deputy Director General until 2000, when she was appointed as Director General for Spain. In 2005, she joined Wyeth’s US headquarters to develop a global project, reporting to the CEO of the company, for the restructuration of Wyeth’s affiliates at global level. In 2007, she returned to Spain as General Director for Spain and Portugal. Following the acquisition of Wyeth by Pfizer in October 2009, she was named President and Director General, a position she held until 2015.
Elvira Sanz has been a member of the Board of Directors of the American Business Council and of the American Chamber of Commerce, and has been the President of LAWG (Laboratories Accreditation Working Group) in the period 2010-2012. From 2010 to 2014, she was Vice-President and then President of Farmaindustria, the Spanish pharmaceutical industry association.